Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Research Highlight
  • Published:

Benefits of abciximab for patients with ischemic stroke

Nature Clinical Practice Cardiovascular Medicine volume 2, page 615 (2005)Cite this article

This article has been updated

Mitsias PD et al. (2005) MRI-guided, open trial of abciximab for ischemic stroke within a 3- to 24-hour window. Neurology 65: 612–615

Abciximab could have beneficial effects on neurological status and size of ischemic lesions in patients with ischemic stroke, an MRI-guided trial has shown.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to the full article PDF.

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Change history

  • 17 May 2018

    This article was published with the same DOI as a previous publication. A new DOI has been assigned and registered at Crossref, and has been corrected in the article.

Authors
  1. Claire Braybrook
    View author publications

    Search author on:PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Braybrook, C. Benefits of abciximab for patients with ischemic stroke. Nat Rev Cardiol 2, 615 (2005). https://doi.org/10.1038/ncpneuro0025x

Download citation

  • Issue date:

  • DOI: https://doi.org/10.1038/ncpneuro0025x

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing